(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.94%) $83.06
(-1.16%) $1.619
(-0.28%) $2 340.60
(-0.02%) $27.53
(0.50%) $926.70
(-0.16%) $0.933
(-0.15%) $11.01
(-0.24%) $0.798
(0.00%) $92.17
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 8.14%
-0.54% $ 21.98
@ $28.94
Wydano: 14 vas. 2024 @ 20:53
Zwrot: -24.05%
Poprzedni sygnał: vas. 13 - 22:50
Poprzedni sygnał:
Zwrot: 0.59 %
Live Chart Being Loaded With Signals
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 858 483 |
Średni wolumen | 728 017 |
Kapitalizacja rynkowa | 1.99B |
EPS | $0 ( 2024-02-26 ) |
Następna data zysków | ( $-0.690 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.53 |
ATR14 | $0.0190 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-22 | Militello John | Sell | 833 | Common Stock |
2024-04-12 | Southwell David P | Buy | 70 000 | Common Stock |
2024-04-15 | Southwell David P | Buy | 29 624 | Common Stock |
2024-04-15 | Southwell David P | Sell | 10 000 | Common Stock |
2024-04-12 | Southwell David P | Sell | 59 716 | Common Stock |
INSIDER POWER |
---|
41.55 |
Last 97 transactions |
Buy: 5 078 928 | Sell: 2 246 729 |
Wolumen Korelacja
Rocket Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rocket Pharmaceuticals Korelacja - Waluta/Towar
Rocket Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-7.10M (0.00 %) |
EPS: | $-2.92 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-7.10M (0.00 %) |
EPS: | $-2.92 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-6.27M (0.00 %) |
EPS: | $-3.22 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.67 |
Financial Reports:
No articles found.
Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej